Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (431-440 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|October 16, 2019
The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trialCharlotte Pawlyn, David Cairns, Martin Kaiser, et al.
Leukemia|October 16, 2019
T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocolP Quist-Paulsen, N Toft, M Heyman, et al.
Leukemia|October 19, 2019
Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndromeJibran Durrani, Hassan Awada, Ashwin Kishtagari, et al.
Leukemia|October 19, 2019
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I/II studyMarthe C J Roex, Peter van Balen, Lothar Germeroth, et al.
Leukemia|April 20, 2022
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationLucas C Zarling, Megan Othus, Brenda M Sandmaier, et al.
Leukemia|April 20, 2022
Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
Leukemia|April 23, 2022
Cytogenetics or MRD in B-cell ALL. Do both reign supreme?Yishai Ofran, Jacob M Rowe
Leukemia|April 27, 2022
Development of [<sup>211</sup>At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignanciesGeorge S Laszlo, Johnnie J Orozco, Allie R Kehret, et al.
Leukemia|April 24, 2022
Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemiaAlec W Stranahan, Iryna Berezniuk, Sohini Chakraborty, et al.
Leukemia|October 7, 2021
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AMLMatthieu Duchmann, Orianne Wagner-Ballon, Thomas Boyer, et al.
Pageof 1,398

Showing results (431-440 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|October 16, 2019
The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trialCharlotte Pawlyn, David Cairns, Martin Kaiser, et al.
Leukemia|October 16, 2019
T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocolP Quist-Paulsen, N Toft, M Heyman, et al.
Leukemia|October 19, 2019
Large granular lymphocytic leukemia coexists with myeloid clones and myelodysplastic syndromeJibran Durrani, Hassan Awada, Ashwin Kishtagari, et al.
Leukemia|October 19, 2019
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I/II studyMarthe C J Roex, Peter van Balen, Lothar Germeroth, et al.
Leukemia|April 20, 2022
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationLucas C Zarling, Megan Othus, Brenda M Sandmaier, et al.
Leukemia|April 20, 2022
Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
Leukemia|April 23, 2022
Cytogenetics or MRD in B-cell ALL. Do both reign supreme?Yishai Ofran, Jacob M Rowe
Leukemia|April 27, 2022
Development of [<sup>211</sup>At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignanciesGeorge S Laszlo, Johnnie J Orozco, Allie R Kehret, et al.
Leukemia|April 24, 2022
Leukotrienes promote stem cell self-renewal and chemoresistance in acute myeloid leukemiaAlec W Stranahan, Iryna Berezniuk, Sohini Chakraborty, et al.
Leukemia|October 7, 2021
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AMLMatthieu Duchmann, Orianne Wagner-Ballon, Thomas Boyer, et al.
Pageof 1,398